Profile data is unavailable for this security.
About the company
Hainan Huluwa Pharmaceutical Group Co Ltd is a China-based company principally engaged in the production, research and development and sales of pharmaceuticals. The Company's products cover the fields of children's medicines, nutritional supplements, health foods, special medical foods, medical devices and others. The Company's main products include Xiaoer Feire Kechuan Granules, Changyanning Granules/Capsules, Keke Tablets and others. The Company's pharmaceutical business includes respiratory system, digestive system, anti-infection and nutritional supplements. The Company sells its products under the Huluwa brand. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)902.48m
- Net income in CNY-369.56m
- Incorporated2005
- Employees2.10k
- LocationHainan Huluwa Pharmaceutical Group Co LtdNo. 30, Andu 1st Road, Xiuying DistrictHAIKOU 570311ChinaCHN
- Phone+86 89 868634767
- Fax+86 89 868631245
- Websitehttp://www.huluwayaoye.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Tianmushan Phrmtcl ntrprs C Ltd | 251.56m | 33.15m | 2.46bn | 362.00 | 74.12 | 36.90 | -- | 9.77 | 0.2723 | 0.2723 | 2.07 | 0.5468 | 0.632 | 2.97 | 2.32 | 694,905.80 | 8.32 | -8.84 | 27.42 | -25.80 | 47.93 | 32.17 | 13.17 | -21.83 | 0.655 | 9.23 | 0.648 | -- | 78.44 | -6.06 | 139.83 | -21.36 | -26.32 | -- |
| Jiangsu gdk Biotechnology Co Ltd | 116.56m | -126.51m | 2.47bn | 452.00 | -- | 2.07 | -- | 21.15 | -1.03 | -1.03 | 0.9461 | 9.67 | 0.0775 | 0.7322 | 1.14 | 257,878.40 | -8.42 | 1.65 | -9.84 | 2.14 | 60.80 | 73.17 | -108.54 | 7.56 | 1.83 | -- | 0.0465 | 53.80 | -39.96 | 3.77 | -31.71 | -- | 12.74 | -- |
| Zhejiang East Asia Pharmaceutical Co Ltd | 831.56m | -218.24m | 2.51bn | 1.75k | -- | 1.38 | -- | 3.01 | -1.97 | -1.97 | 7.34 | 15.80 | 0.2409 | 0.8634 | 5.60 | 475,447.80 | -6.33 | 2.47 | -8.09 | 3.12 | 25.78 | 24.66 | -26.25 | 5.78 | 0.7513 | -411.46 | 0.3533 | 42.92 | -11.66 | 3.93 | -183.02 | -- | 29.64 | -- |
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 902.48m | -369.56m | 2.71bn | 2.10k | -- | 3.93 | -- | 3.00 | -0.9236 | -0.9236 | 2.26 | 1.72 | 0.3055 | 1.74 | 1.60 | 429,141.60 | -12.36 | 0.2178 | -22.13 | 0.3739 | 31.53 | 54.80 | -40.47 | 0.3213 | 0.5566 | -6.97 | 0.6414 | 700.10 | -21.26 | 1.60 | -2,629.23 | -- | 21.75 | -- |
| Zhejiang Shapuaisi Pharmaceutical Co Ltd | 475.19m | -65.05m | 2.84bn | 1.33k | -- | 1.76 | -- | 5.98 | -0.1796 | -0.1796 | 1.27 | 4.31 | 0.2236 | 2.35 | 14.31 | 357,822.00 | -3.08 | -2.12 | -3.66 | -2.49 | 50.11 | 55.38 | -13.78 | -7.33 | 0.8289 | -0.9506 | 0.1587 | -- | -24.96 | -1.27 | -585.85 | -- | 44.50 | -- |
| Shanghai Serum Bio-Technology Co Ltd | 196.76m | 45.55m | 2.93bn | 326.00 | 64.21 | 2.60 | -- | 14.87 | 0.4209 | 0.4209 | 1.82 | 10.40 | 0.1706 | 1.22 | 3.20 | 603,567.30 | 3.95 | 7.64 | 4.04 | 7.87 | 76.68 | 78.94 | 23.15 | 30.08 | 27.50 | -- | 0.0035 | 77.34 | 2.51 | 0.7147 | 14.23 | -7.60 | 18.77 | -- |
Data as of Feb 11 2026. Currency figures normalised to Hainan Huluwa Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Orient Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
